Cargando…

Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) is characterized by amyloid deposition, tangle formation as well as synapse loss. Synaptic abnormalities occur early in the pathogenesis of AD. Identifying early synaptic abnormalities and their underlying mechanisms is likely important for the prevention and tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yang, Li, Miao, Zhou, Yanmei, Ma, Lei, Qiao, Qian, Hu, Wanling, Li, Wei, Wills, Zachary Patrick, Gan, Wen-Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686812/
https://www.ncbi.nlm.nih.gov/pubmed/29137651
http://dx.doi.org/10.1186/s13024-017-0228-2
_version_ 1783278840010768384
author Bai, Yang
Li, Miao
Zhou, Yanmei
Ma, Lei
Qiao, Qian
Hu, Wanling
Li, Wei
Wills, Zachary Patrick
Gan, Wen-Biao
author_facet Bai, Yang
Li, Miao
Zhou, Yanmei
Ma, Lei
Qiao, Qian
Hu, Wanling
Li, Wei
Wills, Zachary Patrick
Gan, Wen-Biao
author_sort Bai, Yang
collection PubMed
description BACKGROUND: Alzheimer’s disease (AD) is characterized by amyloid deposition, tangle formation as well as synapse loss. Synaptic abnormalities occur early in the pathogenesis of AD. Identifying early synaptic abnormalities and their underlying mechanisms is likely important for the prevention and treatment of AD. METHODS: We performed in vivo two-photon calcium imaging to examine the activities of somas, dendrites and dendritic spines of layer 2/3 pyramidal neurons in the primary motor cortex in the APPswe/PS1dE9 mouse model of AD and age-matched wild type control mice. We also performed calcium imaging to determine the effect of Aβ oligomers on dendritic calcium activity. In addition, structural and functional two-photon imaging were used to examine the link between abnormal dendritic calcium activity and changes in dendritic spine size in the AD mouse model. RESULTS: We found that somatic calcium activities of layer 2/3 neurons were significantly lower in the primary motor cortex of 3-month-old APPswe/PS1dE9 mice than in wild type mice during quiet resting, but not during running on a treadmill. Notably, a significantly larger fraction of apical dendrites of layer 2/3 pyramidal neurons showed calcium transients with abnormally long duration and high peak amplitudes during treadmill running in AD mice. Administration of Aβ oligomers into the brain of wild type mice also induced abnormal dendritic calcium transients during running. Furthermore, we found that the activity and size of dendritic spines were significantly reduced on dendritic branches with abnormally prolonged dendritic calcium transients in AD mice. CONCLUSION: Our findings show that abnormal dendritic calcium transients and synaptic depotentiation occur before amyloid plaque formation in the motor cortex of the APPswe/PS1dE9 mouse model of AD. Dendritic calcium transients with abnormally long durations and high amplitudes could be induced by soluble Aβ oligomers and contribute to synaptic deficits in the early pathogenesis of AD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13024-017-0228-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5686812
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56868122017-11-21 Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease Bai, Yang Li, Miao Zhou, Yanmei Ma, Lei Qiao, Qian Hu, Wanling Li, Wei Wills, Zachary Patrick Gan, Wen-Biao Mol Neurodegener Research Article BACKGROUND: Alzheimer’s disease (AD) is characterized by amyloid deposition, tangle formation as well as synapse loss. Synaptic abnormalities occur early in the pathogenesis of AD. Identifying early synaptic abnormalities and their underlying mechanisms is likely important for the prevention and treatment of AD. METHODS: We performed in vivo two-photon calcium imaging to examine the activities of somas, dendrites and dendritic spines of layer 2/3 pyramidal neurons in the primary motor cortex in the APPswe/PS1dE9 mouse model of AD and age-matched wild type control mice. We also performed calcium imaging to determine the effect of Aβ oligomers on dendritic calcium activity. In addition, structural and functional two-photon imaging were used to examine the link between abnormal dendritic calcium activity and changes in dendritic spine size in the AD mouse model. RESULTS: We found that somatic calcium activities of layer 2/3 neurons were significantly lower in the primary motor cortex of 3-month-old APPswe/PS1dE9 mice than in wild type mice during quiet resting, but not during running on a treadmill. Notably, a significantly larger fraction of apical dendrites of layer 2/3 pyramidal neurons showed calcium transients with abnormally long duration and high peak amplitudes during treadmill running in AD mice. Administration of Aβ oligomers into the brain of wild type mice also induced abnormal dendritic calcium transients during running. Furthermore, we found that the activity and size of dendritic spines were significantly reduced on dendritic branches with abnormally prolonged dendritic calcium transients in AD mice. CONCLUSION: Our findings show that abnormal dendritic calcium transients and synaptic depotentiation occur before amyloid plaque formation in the motor cortex of the APPswe/PS1dE9 mouse model of AD. Dendritic calcium transients with abnormally long durations and high amplitudes could be induced by soluble Aβ oligomers and contribute to synaptic deficits in the early pathogenesis of AD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13024-017-0228-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-14 /pmc/articles/PMC5686812/ /pubmed/29137651 http://dx.doi.org/10.1186/s13024-017-0228-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bai, Yang
Li, Miao
Zhou, Yanmei
Ma, Lei
Qiao, Qian
Hu, Wanling
Li, Wei
Wills, Zachary Patrick
Gan, Wen-Biao
Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
title Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
title_full Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
title_fullStr Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
title_full_unstemmed Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
title_short Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
title_sort abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of alzheimer’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686812/
https://www.ncbi.nlm.nih.gov/pubmed/29137651
http://dx.doi.org/10.1186/s13024-017-0228-2
work_keys_str_mv AT baiyang abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT limiao abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT zhouyanmei abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT malei abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT qiaoqian abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT huwanling abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT liwei abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT willszacharypatrick abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT ganwenbiao abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease